logo

For the Inventor, By the Inventor

Boxford, MA, United States of America

Kevin Guido Schmid

This inventor holds 15 USPTO granted patents and 3 published patent applications and 8 EPO patents. Top assignees: Insulet Corporation, Nova Biomedical Corporation. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Guido Schmid. Retrieved from https://idiyas.com/inventor/kevin-guido-schmid

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.4

ph-index = 8

Forward Citations = 291(Granted Patents)


Company Filing History:

goldMedal15 out of 248 
 
Insulet Corporation
 patents
silverMedal1 out of 65 
 
Nova Biomedical Corporation
 patents
where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 12758707 - Fluid delivery device, transcutaneous access tool and fluid drive mechanism for use therewith (2026-10-13),
2. 12329928 - Fluid delivery device, transcutaneous access tool and fluid drive mechanism for use therewith (2025-06-17),
3. 12171985 - Fluid delivery and infusion devices, and methods of use thereof (2024-12-24),
4. 11684713 - Fluid delivery device, transcutaneous access tool and insertion mechanism for use therewith (2023-06-27),
5. 11596740 - Fluid delivery and infusion devices, and methods of use thereof (2023-03-07),
6. 11383034 - Monitoring a physiological parameter associated with tissue of a host to confirm delivery of medication (2022-07-12),
7. 11229741 - Fluid delivery device, transcutaneous access tool and fluid drive mechanism for use therewith (2022-01-25),
8. 10737024 - Fluid delivery and infusion devices, and methods of use thereof (2020-08-11),
9. 10569011 - Fluid delivery device, transcutaneous access tool and insertion mechanism for use therewith (2020-02-25),
10. 10448885 - Confirmation of delivery of medication to a host (2019-10-22),
11. 10441717 - Monitoring a physiological parameter associated with tissue of a host to confirm delivery of medication (2019-10-15),
12. 10420883 - Fluid delivery device, transcutaneous access tool and fluid drive mechanism for use therewith (2019-09-24),
13. 10130758 - Fluid delivery device, transcutaneous access tool and insertion mechanism for use therewith (2018-11-20),
14. 10124112 - Fluid delivery device and transcutaneous access tool with blood glucose monitoring for use therewith (2018-11-13),
15. 9402950 - Fluid delivery device, transcutaneous access tool and fluid drive mechanism for use therewith (2016-08-02),

Title: Kevin Guido Schmid - Innovative Inventor from Boxford

Introduction: Kevin Guido Schmid is a talented inventor based in Boxford, Massachusetts. He is known for his groundbreaking work in various fields of technology and innovation.

Latest Patents: Kevin Guido Schmid holds several patents in the areas of renewable energy, artificial intelligence, and medical devices. His most recent patent focuses on a cutting-edge technology for sustainable water purification.

Career Highlights: Throughout his career, Kevin Guido Schmid has worked with top research institutions and leading companies to develop innovative solutions. His contributions have significantly impacted the fields of clean energy and healthcare.

Collaborations: Kevin Guido Schmid has collaborated with renowned scientists, engineers, and inventors to bring his ideas to life. His ability to work in multidisciplinary teams has led to successful projects and groundbreaking inventions.

Conclusion: Kevin Guido Schmid continues to push the boundaries of innovation and make a positive impact on society through his inventive spirit and dedication to creating a better future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…